Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20222 results available
- November 20221 results available
- October 20221 results available
- August 20224 results available
- June 20221 results available
- April 20221 results available
- March 20223 results available
- February 20226 results available
- January 20227 results available
Recall class
Displaying 16 - 26 of 26 items.
Octagam 10% (Immune globulin intravenous, Human):Quality issue
RecallHealth product recall | 2022-02-23
Odan Itraconazole: Out of specification
RecallHealth product recall | 2022-02-23
Auralgan: Impurities out of specification
RecallHealth product recall | 2022-02-04
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
Reddy-Dasatinib: out of specification
RecallHealth product recall | 2022-01-31
APO-AMITRIPTYLINE 10mg: NDMA impurity
RecallHealth product recall | 2022-01-26
ELAVIL 10mg: NDMA impurity
RecallHealth product recall | 2022-01-26
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
Piperacillin and Tazobactam for injection: Particulate
RecallHealth product recall | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12